GlassScriptPhysician profile
Lindsey E Baxter
NPI 1104291483
$4,364.35
in general payments reported to CMS, 2019-2025
13 companies · $1,491 in 2025
The $1,491 reported for 2025 was more than what 92% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $477 · 2022: $764 · 2023: $541 · 2024: $1,092 · 2025: $1,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,357 · Travel and Lodging: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,357.34 |
| Travel and Lodging | $765.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,847.31 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $470.90 | 2021-2025 | Lifevest |
| Abiomed | $229.81 | 2023-2024 | Impella |
| Kestra Medical Technology Services, INC. | $178.83 | 2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $141.40 | 2025 | Amvuttra |
| Livanova USA, INC. | $140.01 | 2021 | |
| Itamar Medical INC | $112.38 | 2021 | |
| Cvrx, INC. | $68.78 | 2025 | Barostim Neo System |
| Inspire Medical Systems, INC. | $42.83 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $42.03 | 2021 | |
| Pfizer INC. | $40.39 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.41 | 2025 | Jardiance |
| Scpharmaceuticals INC. | $18.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.